Lynn Stockwell - CEO and Exe. Chair of Board, Director, 10%+ Owner at Drugs Made In America Acquisition II Corp.

Issuer-level insider activity

Role: CEO and Exe. Chair of Board, Director, 10%+ Owner
Issuer ticker: DMII, DMIIR, DMIIU on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Lynn Stockwell since 06 Oct 2025

Reported holdings for Lynn Stockwell in Drugs Made In America Acquisition II Corp.

Form 4 holding CEO and Exe. Chair of Board, Director, 10%+ Owner

Drugs Made In America Acquisition II Corp.

Security class: Ordinary shares
Shares / value: 6,708,333
Estimated value
Report date: 26 Sep 2025
Price
Ownership: Indirect

Transaction history for Lynn Stockwell in Drugs Made In America Acquisition II Corp.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .